Health-ITNews

Rakuten Medical in strategic partnership with Karkinos Healthcare 

To expand cancer care reach

Rakuten Medical and Karkinos Healthcare announced a strategic collaboration to expand the reach of novel cancer care to India. This includes a minority stake acquisition in Karkinos Healthcare by Rakuten Medical. Rakuten Medical’s investment marks Karkinos Healthcare’s first international investor. 

Rakuten Medical is focussed on developing and commercialising innovative cancer treatments for multiple indications based on its Illuminox platform. Karkinos is a healthcare technology platform focussed on delivering quality healthcare by providing access to, and availability of, cancer detection, diagnosis and treatment options. The strategic collaboration will enable continued innovation in cancer care to transform cancer care in India and abroad.  

Rakuten Medical’s first pipeline drug developed on its Illuminox platform, ASP-1929, has received approval from the Japanese Ministry of Health, Labour, and Welfare, and is currently the subject of a global phase 3 clinical trial for recurrent head and neck cancer. Karkinos Healthcare is pioneering the Distributed Cancer Care Network model in India addressing clinical needs that will bring quality care closer to patients. Karkinos already offers its services in Kothamangalam, Chottanikkara, Thodupuzha, Munnar locations across Ernakulam and Idukki Districts, in Kerala and is planning to ramp up its operations across India.

“We are happy to partner with Karkinos Healthcare, who is committed to transforming cancer care”, said Mickey Mikitani, CEO, Rakuten Medical. “We believe this partnership will open up more opportunities for cancer patients in the Indian market, help Rakuten Medical further develop and commercialize our treatment based on our Illuminox platform, and ultimately deliver on our mission to bring this technology to as many patients as possible”.

“Our collaboration with Rakuten Medical will allow us to introduce their breakthrough therapies and vital support structure for cancer patients in India”, said Venkataramanan R, CEO, Karkinos Healthcare. “We at Karkinos believe platforms like Rakuten Medical’s Illuminox platform can revolutionise cancer care in the country and beyond.” 

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close